Literature DB >> 23915883

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

F Gerald R Fowkes1, Diana Rudan, Igor Rudan, Victor Aboyans, Julie O Denenberg, Mary M McDermott, Paul E Norman, Uchechukwe K A Sampson, Linda J Williams, George A Mensah, Michael H Criqui.   

Abstract

BACKGROUND: Lower extremity peripheral artery disease is the third leading cause of atherosclerotic cardiovascular morbidity, following coronary artery disease and stroke. This study provides the first comparison of the prevalence of peripheral artery disease between high-income countries (HIC) and low-income or middle-income countries (LMIC), establishes the primary risk factors for peripheral artery disease in these settings, and estimates the number of people living with peripheral artery disease regionally and globally.
METHODS: We did a systematic review of the literature on the prevalence of peripheral artery disease in which we searched for community-based studies since 1997 that defined peripheral artery disease as an ankle brachial index (ABI) lower than or equal to 0·90. We used epidemiological modelling to define age-specific and sex-specific prevalence rates in HIC and in LMIC and combined them with UN population numbers for 2000 and 2010 to estimate the global prevalence of peripheral artery disease. Within a subset of studies, we did meta-analyses of odds ratios (ORs) associated with 15 putative risk factors for peripheral artery disease to estimate their effect size in HIC and LMIC. We then used the risk factors to predict peripheral artery disease numbers in eight WHO regions (three HIC and five LMIC).
FINDINGS: 34 studies satisfied the inclusion criteria, 22 from HIC and 12 from LMIC, including 112,027 participants, of which 9347 had peripheral artery disease. Sex-specific prevalence rates increased with age and were broadly similar in HIC and LMIC and in men and women. The prevalence in HIC at age 45-49 years was 5·28% (95% CI 3·38-8·17%) in women and 5·41% (3·41-8·49%) in men, and at age 85-89 years, it was 18·38% (11·16-28·76%) in women and 18·83% (12·03-28·25%) in men. Prevalence in men was lower in LMIC than in HIC (2·89% [2·04-4·07%] at 45-49 years and 14·94% [9·58-22·56%] at 85-89 years). In LMIC, rates were higher in women than in men, especially at younger ages (6·31% [4·86-8·15%] of women aged 45-49 years). Smoking was an important risk factor in both HIC and LMIC, with meta-OR for current smoking of 2·72 (95% CI 2·39-3·09) in HIC and 1·42 (1·25-1·62) in LMIC, followed by diabetes (1·88 [1·66-2·14] vs 1·47 [1·29-1·68]), hypertension (1·55 [1·42-1·71] vs 1·36 [1·24-1·50]), and hypercholesterolaemia (1·19 [1·07-1·33] vs 1·14 [1·03-1·25]). Globally, 202 million people were living with peripheral artery disease in 2010, 69·7% of them in LMIC, including 54·8 million in southeast Asia and 45·9 million in the western Pacific Region. During the preceding decade the number of individuals with peripheral artery disease increased by 28·7% in LMIC and 13·1% in HIC.
INTERPRETATION: In the 21st century, peripheral artery disease has become a global problem. Governments, non-governmental organisations, and the private sector in LMIC need to address the social and economic consequences, and assess the best strategies for optimum treatment and prevention of this disease. FUNDING: Peripheral Arterial Disease Research Coalition (Europe).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23915883     DOI: 10.1016/S0140-6736(13)61249-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  743 in total

1.  Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure.

Authors:  Jun-Ichiro Koga; Toshiaki Nakano; James E Dahlman; Jose-Luiz Figueiredo; Hengmin Zhang; Julius Decano; Omar F Khan; Tomiharu Niida; Hiroshi Iwata; Jon C Aster; Hideo Yagita; Daniel G Anderson; C Keith Ozaki; Masanori Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-24       Impact factor: 8.311

2.  Effect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Shari R Waldstein; Polly S Montgomery; Yan D Zhao
Journal:  J Vasc Surg       Date:  2015-10-23       Impact factor: 4.268

3.  Consensus recommendations for essential vascular care in low- and middle-income countries.

Authors:  Barclay T Stewart; Adam Gyedu; Christos Giannou; Brijesh Mishra; Norman Rich; Sherry M Wren; Charles Mock; Adam L Kushner
Journal:  J Vasc Surg       Date:  2016-07-16       Impact factor: 4.268

4.  Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.

Authors:  Lingdan Chen; Emmanuel Okeke; Dawit Ayalew; Danny Wang; Lyeba Shahid; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-21

5.  A risk score assessment tool for peripheral arterial disease in women: From the National Health and Nutrition Examination Survey.

Authors:  Hend Mansoor; Islam Y Elgendy; Renessa S Williams; Verlin W Joseph; Young-Rock Hong; Arch G Mainous
Journal:  Clin Cardiol       Date:  2018-08-17       Impact factor: 2.882

6.  Successful carbon dioxide angiography guided endovascular thrombectomy of the superficial femoral artery in a young patient with critical limb ischemia.

Authors:  Sorin Giusca; Tom Eisele; Dorothea Raupp; Christoph Eisenbach; Grigorios Korosoglou
Journal:  Heart Vessels       Date:  2016-09-23       Impact factor: 2.037

Review 7.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

8.  Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness.

Authors:  Sangmo Hong; Munsuk Nam; Bertis B Little; Seihyun Paik; Kwanwoo Lee; Jungtaek Woo; Dooman Kim; Jungoo Kang; Minyoung Chun; Yongsoo Park
Journal:  Heart Vessels       Date:  2019-05-06       Impact factor: 2.037

9.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

10.  Coronary Exercise Hyperemia Is Impaired in Patients with Peripheral Arterial Disease.

Authors:  Amanda J Ross; Zhaohui Gao; Jonathan Carter Luck; Cheryl A Blaha; Aimee E Cauffman; Faisal Aziz; John F Radtka; David N Proctor; Urs A Leuenberger; Lawrence I Sinoway; Matthew D Muller
Journal:  Ann Vasc Surg       Date:  2016-08-27       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.